Amyloid Solution Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants (NCT06786676) | Amyloid Solution Inc | 2025-05-26 |
Track Amyloid Solution Inc automatically
Every clearance here is in the API, with alerts when new ones post.